On 18 May 2020, Advaxis, Inc. (NASDAQ: ADXS) stock observed trading -77.71% off 52-week high price. On the other end, the stock has been noted 244.32% away from low price over the last 52-weeks. The stock disclosed a move of 12.05% away from 50 day moving average and 18.19% away from 200 day moving average. Moving closer, we can see that shares have been trading 4.26% off 20-day moving average.
Advaxis, Inc. (ADXS) recently reported an update on its clinical pipeline and financial results for the first quarter ended January 31, 2020.
First Quarter Ended January 31, 2020 Financial Results
During the quarter ended January 31, 2019, the Company recognized $19.4M in revenue associated with the revenue recognition requirements surrounding the termination of the alliance contract with Amgen in 2019; no similar situation existed during the fiscal quarter ended January 31, 2020.
Research and development expenses for the first quarter of fiscal year 2020 were $4.9M, contrast with $6.7M for the first quarter of fiscal year 2019. The decrease is largely attributable to the winding down of our Phase 3 AIM2CERV and Phase 1 ADXS-NEO studies as reported in June 2019 and October 2019, respectively.
General and administrative expenses for the three months ended January 31, 2020 were about $3.0M contrast to $2.7M in the same three-month period in 2019 as a result of higher business development and legal fees.
As of January 31, 2020, the Company had about $34.2M in cash and cash equivalents. The Company believes this is sufficient capital to fund its obligations, as they become due, in the ordinary course of business until at least mid-2021.
The USA based company Advaxis, Inc. moved with change of -3.80% to $0.71 with the total traded volume of 899351 shares in recent session versus to an average volume of 2116.96K. ADXS’s shares are at -27.32% for the quarter and driving a -75.69% return over the course of the past year and is now at -14.41% since this point in 2018. Right now, the stock beta is 3.5. The average volatility for the week and month was at 11.95% and 9.51% respectively. There are 51.75M shares outstanding and 57.9M shares are floated in market.